Predictive value of EGFR mutation in non–small‐cell lung cancer patients treated with platinum doublet postoperative chemotherapy-Reference-Cited by-同舟云学术

Predictive value of EGFR mutation in non–small‐cell lung cancer patients treated with platinum doublet postoperative chemotherapy

Published:2021-11-07 Issue:1 Volume:113 Page:287-296
ISSN:1347-9032
Container-title:Cancer Science
language:en
Short-container-title:Cancer Science

Author:

Takahashi Toshiaki¹,Sakai Kazuko²^ORCID,Kenmotsu Hirotsugu¹^ORCID,Yoh Kiyotaka³^ORCID,Daga Haruko⁴,Ohira Tatsuo⁵,Ueno Tsuyoshi⁶,Aoki Tadashi⁷,Hayashi Hidetoshi⁸^ORCID,Yamazaki Koji⁹,Hosomi Yukio¹⁰,Chen‐Yoshikawa Toyofumi F.¹¹,Okumura Norihito¹²^ORCID,Takiguchi Yuichi¹³^ORCID,Sekine Akimasa¹⁴,Haruki Tomohiro¹⁵,Yamamoto Hiromasa¹⁶^ORCID,Sato Yuki¹⁷,Akamatsu Hiroaki¹⁸,Seto Takashi¹⁹,Saeki Sho²⁰,Sugio Kenji²¹,Nishio Makoto²²^ORCID,Inokawa Hidetoshi²³,Yamamoto Nobuyuki¹⁸,Nishio Kazuto²^ORCID,Tsuboi Masahiro²⁴

Affiliation:

1. Division of Thoracic Oncology Shizuoka Cancer Center Nagaizumi‐cho, Sunto‐gun Japan

2. Department of Genome Biology Kindai University Faculty of Medicine Osaka‐sayama Japan

3. Department of Thoracic Oncology National Cancer Center Hospital East Kashiwa Japan

4. Department of Medical Oncology Osaka City General Hospital Osaka Japan

5. Department of Surgery Tokyo Medical University Tokyo Japan

6. Department of Thoracic Surgery National Hospital Organization Shikoku Cancer Center Matsuyama Japan

7. Department of Chest Surgery Niigata Cancer Center Hospital Niigata Japan

8. Department of Medical Oncology Kindai University Faculty of Medicine Osaka‐Sayama Japan

9. Department of Thoracic Surgery Clinical Research Institute National Hospital Organization Kyushu Medical Center Fukuoka Japan

10. Department of Thoracic Oncology and Respiratory Medicine Tokyo Metropolitan Cancer and Infectious Diseases Center Komagome Hospital Tokyo Japan

11. Department of Thoracic Surgery Nagoya University Graduate School of Medicine Nagoya Japan

12. Department of Thoracic Surgery Kurashiki Central Hospital Kurashiki Japan

13. Department of Medical Oncology Chiba University Hospital Chiba Japan

14. Department of Respiratory Medicine Kanagawa Cardiovascular and Respiratory Center Yokohama Japan

15. Division of General Thoracic Surgery Department of Surgery Faculty of Medicine Tottori University Tottori Japan

16. Department of Thoracic Surgery Okayama University Hospital Okayama Japan

17. Department of Respiratory Medicine Kobe City Medical Center General Hospital Kobe Japan

18. Internal Medicine III Wakayama Medical University Wakayama Japan

19. Department of Thoracic Oncology National Hospital Organization Kyushu Cancer Center Fukuoka Japan

20. Department of Respiratory Medicine Kumamoto University Hospital Kumamoto Japan

21. Department of Thoracic and Breast Surgery Oita University Oita Japan

22. Department of Thoracic Medical Oncology The Cancer Institute Hospital Japanese Foundation For Cancer Research Tokyo Japan

23. Division of Thoracic Surgery Yamaguchi Ube Medical Center Ube Japan

24. Division of Thoracic Surgery National Cancer Center Hospital East Kashiwa Japan

Publisher

Wiley

Subject

Cancer Research,Oncology,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/cas.15171

Reference32 articles.

1. Lung Adjuvant Cisplatin Evaluation: A Pooled Analysis by the LACE Collaborative Group

2. Vinorelbine plus Cisplatin vs. Observation in Resected Non–Small-Cell Lung Cancer

3. Randomized Phase III Study of Pemetrexed Plus Cisplatin Versus Vinorelbine Plus Cisplatin for Completely Resected Stage II to IIIA Nonsquamous Non–Small-Cell Lung Cancer

4. Mutation incidence and coincidence in non small-cell lung cancer: meta-analyses by ethnicity and histology (mutMap)

5. ADAURA: Phase III, Double-blind, Randomized Study of Osimertinib Versus Placebo in EGFR Mutation-positive Early-stage NSCLC After Complete Surgical Resection

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The effect of epidermal growth factor receptor mutation on adjuvant chemotherapy with tegafur/uracil for patients with completely resected, non-lymph node metastatic non-small cell lung cancer (> 2 cm): a multicenter, retrospective, observational study as exploratory analysis of the CSPOR-LC03 study;Japanese Journal of Clinical Oncology;2024-09-11

2. The promise and challenges of genomics‐informed periodontal disease diagnoses;Periodontology 2000;2024-06

3. Ad(aura): a fresh breeze for patients with resected EGFR-mutant non-small cell lung cancer;Chinese Clinical Oncology;2024-04

4. Impact of central nervous system metastasis after complete resection of lung adenocarcinomas harboring common EGFR mutation – A real-world database study in Japan: The CReGYT-01 EGFR study;European Journal of Cancer;2024-04

5. Osimertinib in the treatment of resected EGFR-mutated non-small cell lung cancer: a cost-effectiveness analysis in the United States;Frontiers in Pharmacology;2024-03-28